|
S.No |
Applications |
Resource |
|
1 |
Upregulation of
Putaminal Dopamine D2 Receptors in Early Parkinson's
Disease: A Comparative PET Study with [11C]Raclopride
and [11C]N-Methylspiperone |
Valtteri Kaasinen, et al. J Nucl Med. 2000, 41, 65. |
|
2 |
Levodopa-induced changesin synaptic dopamine in patients with
Parkinson's disease as
measured by [11C]raclopride
displacement and PET |
Tedroff J, et al. Neurology. 1996, 46, 1430. |
|
3 |
Long-term changes of striatal dopamine D2 receptors in patients with
Parkinson's disease: a study with positron emission tomography and
[11C]raclopride
|
Antonini A, et al. Mov Disord 1997b, 12, 33. |
|
4 |
Stress-induced
dopamine release in humans at risk of psychosis: a [11C]raclopride PET study |
Soliman A, et al. Neuropsychopharmacology. 2008,
33, 2033. |
|
5 |
Heterogeneous
effects of alcohol on dopamine release in the striatum: a PET
study |
Yoder KK, et al. Alcohol
Clin Exp Res. 2007, 31, 965. |
|
6 |
Smoking modulation of mu-opioid and
dopamine D2 receptor-mediated neurotransmission in humans |
Scott DJ, et al.
Neuropsychopharmacology. 2007, 32, 450. |
|
7 |
Elevated putamen D(2) receptor binding potential in major depression with motor
retardation: an [11C]raclopride positron emission tomography study |
Meyer JH, et al. Am J
Psychiatry, 2006, 163, 1594. |